Midcareer Investigator Award in Alcohol-Related Human Disease Research

酒精相关人类疾病研究职业中期研究员奖

基本信息

  • 批准号:
    7233687
  • 负责人:
  • 金额:
    $ 14.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-05-20 至 2011-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Alcohol abuse is the single most common known and preventable cause of birth defects, and a major contributor to both chronic liver disease and neurodegeneration in the United States. Our research has linked several chronic alcohol exposure-mediated abnormalities in brain and liver function to impairments in insulin and insulin-like growth factor signaling, particularly with regard to cell survival and energy metabolism. However, in order to capitalize on these recent gains, it will be necessary to extend the analyses to human disease states using state-of-the-art methodology. The major goals of this proposal are to: 1) investigate mechanisms of alcohol-mediated neurodegeneration in adult human brains using molecular and biochemical approaches; 2) provide a strong, highly supportive environment to train and mentor junior investigators, particularly physician-scientists, to investigate human disease mechanisms by utilizing current technology to analyze human tissue samples; and 3) educate junior investigators about the importance of experimental models for testing hypotheses and validating results from human studies. Emphasis will be placed on including women and minority trainees. Suzanne M. De la Monte is a Pathologist and Neuropathologist by training and clinical activities at the Rhode Island Hospital, and Professor of Pathology and Clinical Neuroscience at Brown University. Dr. De la Monte has a long track record of training young investigators in human disease, biomedical, and translational research. Her laboratory, which currently is supported by NIH funding from NIAAA, hosts several trainees including undergraduates, medical students, graduate students, postdoctoral fellows, and junior physician-scientists, most of whom are women or members of under-represented minority groups. This Mid-career investigator award will provide better opportunity for Dr. De la Monte to exercise leadership and high quality mentorship and training of promising young scientists. The information included in this application demonstrates a productive career in human and translational research, and demonstrates Dr. De la Monte's commitment to continuing this type of work while mentoring scientists for the future.
描述(由申请人提供):在美国,酒精滥用是导致出生缺陷的最常见的已知和可预防的原因,也是慢性肝病和神经变性的主要原因。我们的研究将几种慢性酒精暴露介导的脑和肝功能异常与胰岛素和胰岛素样生长因子信号的损害联系起来,特别是在细胞存活和能量代谢方面。然而,为了利用这些最近的成果,有必要使用最先进的方法将分析扩展到人类疾病状态。本研究的主要目标是:1)利用分子和生化方法研究酒精介导的成人大脑神经退行性变的机制;2)提供一个强大的、高度支持的环境,培训和指导初级研究人员,特别是医师科学家,利用现有技术分析人体组织样本,研究人类疾病机制;3)教育初级调查员关于……的重要性

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUZANNE M. DE LA MONTE其他文献

SUZANNE M. DE LA MONTE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUZANNE M. DE LA MONTE', 18)}}的其他基金

Pathogenesis of Early- Versus Late-Stage Alcohol-Mediated White Matter Degeneration
早期与晚期酒精介导的白质变性的发病机制
  • 批准号:
    10426054
  • 财政年份:
    2021
  • 资助金额:
    $ 14.89万
  • 项目类别:
Pathogenesis of Early- Versus Late-Stage Alcohol-Mediated White Matter Degeneration
早期与晚期酒精介导的白质变性的发病机制
  • 批准号:
    10598122
  • 财政年份:
    2021
  • 资助金额:
    $ 14.89万
  • 项目类别:
Clinical Evaluation of T3D-959 as a Potential Disease Remedial Therapeutic for the Treatment of Alzheimer's Disease
T3D-959 作为治疗阿尔茨海默病的潜在疾病治疗药物的临床评价
  • 批准号:
    9034522
  • 财政年份:
    2015
  • 资助金额:
    $ 14.89万
  • 项目类别:
Clinical Evaluation of T3D-959 as a Potential Disease Remedial Therapeutic for the Treatment of Alzheimer's Disease
T3D-959 作为治疗阿尔茨海默病的潜在疾病治疗药物的临床评价
  • 批准号:
    8833069
  • 财政年份:
    2015
  • 资助金额:
    $ 14.89万
  • 项目类别:
Short-Term Training Program to Increase Diversity in Health-Related Research
增加健康相关研究多样性的短期培训计划
  • 批准号:
    8851647
  • 财政年份:
    2007
  • 资助金额:
    $ 14.89万
  • 项目类别:
Short-Term Training Program to Increase Diversity in Health-Related Research
增加健康相关研究多样性的短期培训计划
  • 批准号:
    8534236
  • 财政年份:
    2007
  • 资助金额:
    $ 14.89万
  • 项目类别:
Short-Term Training Program to Increase Diversity in Health-Related Research
增加健康相关研究多样性的短期培训计划
  • 批准号:
    8687720
  • 财政年份:
    2007
  • 资助金额:
    $ 14.89万
  • 项目类别:
Midcareer Investigator Award in Alcohol-Related Human Disease Research
酒精相关人类疾病研究职业中期研究员奖
  • 批准号:
    7407991
  • 财政年份:
    2006
  • 资助金额:
    $ 14.89万
  • 项目类别:
Midcareer Investigator Award in Alcohol-Related Human Disease Research
酒精相关人类疾病研究职业中期研究员奖
  • 批准号:
    7620005
  • 财政年份:
    2006
  • 资助金额:
    $ 14.89万
  • 项目类别:
Award:Alcohol-Related Human Disease Research
奖项:与酒精相关的人类疾病研究
  • 批准号:
    7081677
  • 财政年份:
    2006
  • 资助金额:
    $ 14.89万
  • 项目类别:

相似海外基金

Effect of Acetylcholinesterase inhibitors on Bone Metabolism and Fracture Risk Factors among older adults with mild to moderate Alzheimer's Disease
乙酰胆碱酯酶抑制剂对患有轻至中度阿尔茨海默病的老年人骨代谢和骨折危险因素的影响
  • 批准号:
    10739853
  • 财政年份:
    2023
  • 资助金额:
    $ 14.89万
  • 项目类别:
Acetylcholinesterase Complex Protein-Protein Interactions as Drug Targets Against Organophosphate-induced Neurotoxicity.
乙酰胆碱酯酶复合物蛋白质-蛋白质相互作用作为抗有机磷诱导的神经毒性的药物靶点。
  • 批准号:
    10772738
  • 财政年份:
    2023
  • 资助金额:
    $ 14.89万
  • 项目类别:
Machine learning approaches to predict Acetylcholinesterase inhibition
预测乙酰胆碱酯酶抑制的机器学习方法
  • 批准号:
    10378934
  • 财政年份:
    2021
  • 资助金额:
    $ 14.89万
  • 项目类别:
Acetylcholinesterase Complex Protein-Protein Interactions as Drug Targets Against Organophosphate-induced Neurotoxicity.
乙酰胆碱酯酶复合物蛋白质-蛋白质相互作用作为抗有机磷诱导的神经毒性的药物靶点。
  • 批准号:
    10303546
  • 财政年份:
    2021
  • 资助金额:
    $ 14.89万
  • 项目类别:
Investigating the in vivo targets and mechanism of action of a toxic acetylcholinesterase-derived peptide upregulated in Alzheimer's disease
研究阿尔茨海默病中上调的有毒乙酰胆碱酯酶衍生肽的体内靶点和作用机制
  • 批准号:
    2480200
  • 财政年份:
    2020
  • 资助金额:
    $ 14.89万
  • 项目类别:
    Studentship
Improved Therapeutics for the Resurrection of the Aged Form of Acetylcholinesterase
老化乙酰胆碱酯酶复活的改进疗法
  • 批准号:
    9977281
  • 财政年份:
    2019
  • 资助金额:
    $ 14.89万
  • 项目类别:
Improved Therapeutics for the Resurrection of the Aged Form of Acetylcholinesterase
老化乙酰胆碱酯酶复活的改进疗法
  • 批准号:
    10238898
  • 财政年份:
    2019
  • 资助金额:
    $ 14.89万
  • 项目类别:
Elucidation of the cell protective mechanism of acetylcholinesterase variants in cardiomyocyte and approach to therapy for myocardial infarction
心肌细胞乙酰胆碱酯酶变异体的细胞保护机制的阐明及心肌梗死的治疗方法
  • 批准号:
    18K15850
  • 财政年份:
    2018
  • 资助金额:
    $ 14.89万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Alzheimer's disease drugs inhibiting acetylcholinesterase on prion replication.
阿尔茨海默病药物抑制乙酰胆碱酯酶对朊病毒复制的影响。
  • 批准号:
    481759-2015
  • 财政年份:
    2015
  • 资助金额:
    $ 14.89万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Reactivation of Aged Acetylcholinesterase: Design and Development of Novel Therap
老化乙酰胆碱酯酶的重新激活:新型疗法的设计和开发
  • 批准号:
    8735550
  • 财政年份:
    2014
  • 资助金额:
    $ 14.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了